sur SENSORION (EPA:ALSEN)
Sensorion announces its participation in congresses in March 2025
On February 18, 2025, Sensorion, a biotechnology company specializing in therapies for hearing disorders, announced its participation in several conferences in March 2025. Christine Le Bec, Head of Analytical Development, will speak at the “Innovative Biologics and CMC Challenges vol.2” conference in Charleroi, Belgium on March 12. Her presentation will focus on manufacturing challenges related to AAV vectors.
Sensorion will also be present at BIO-Europe Spring in Milan, Italy, from March 17 to 19, 2025. The objective of these participations is to share their advances in hearing therapies, thus strengthening their position in this crucial medical field. These events will provide the company with a platform to discuss current challenges and innovations in hearing biotechnology.
R. H.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de SENSORION